{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:55:31Z","timestamp":1781898931422,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mutations in RNA-binding proteins (RBPs) such as TAR DNA-binding protein 43 (TDP-43) and fused in sarcoma (FUS) are associated with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Recent evidence suggests that RNA dysregulation mediated by aberrant RBPs may play a critical role in neurodegeneration, but the underlying molecular mechanisms are largely unknown. In this study, we performed whole transcriptome profiling of various brain tissues of a transgenic (Tg) mouse model of ALS\/FTD overexpressing the exogenous nuclear localization signal deletion mutant of human FUS (\u0394NLS-FUS) to investigate changes associated with the early stages of ALS\/FTD. Although there were not many differences in expression profiles between wild-type and Tg mice, we found that <jats:italic>Sema3g<\/jats:italic> was significantly upregulated in the frontal cortex and hippocampus of Tg mice. Interestingly, analysis of alternative splicing events identified widespread exons that were differentially regulated in Tg mice in a tissue-specific manner. Our study thus identified aberrant splicing regulation mediated by mutant FUS during the early stages of ALS\/FTD. Targeting this aberrant splicing regulation represents a potential therapeutic strategy for ALS\/FTD.<\/jats:p>","DOI":"10.1038\/s41598-020-61676-x","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T11:02:44Z","timestamp":1584442964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Extensive splicing changes in an ALS\/FTD transgenic mouse model overexpressing cytoplasmic fused in sarcoma"],"prefix":"10.1038","volume":"10","author":[{"given":"Daisuke","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"key":"61676_CR1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Sci. 314, 130\u2013133 (2006).","journal-title":"Sci."},{"key":"61676_CR2","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai, T. et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602\u2013611 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"61676_CR3","doi-asserted-by":"crossref","unstructured":"Ito, D., Hatano, M. & Suzuki, N. RNA binding proteins and the pathological cascade in ALS\/FTD neurodegeneration. Sci Transl Med 9 (2017).","DOI":"10.1126\/scitranslmed.aah5436"},{"key":"61676_CR4","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1212\/WNL.0b013e3182343365","volume":"77","author":"D Ito","year":"2011","unstructured":"Ito, D. & Suzuki, N. Conjoint pathologic cascades mediated by ALS\/FTLD-U linked RNA-binding proteins TDP-43 and FUS. Neurol. 77, 1636\u20131643 (2011).","journal-title":"Neurol."},{"key":"61676_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ana.22246","volume":"69","author":"D Ito","year":"2011","unstructured":"Ito, D., Seki, M., Tsunoda, Y., Uchiyama, H. & Suzuki, N. Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS\/TLS. Ann. Neurol. 69, 152\u2013162 (2011).","journal-title":"Ann. Neurol."},{"key":"61676_CR6","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1074\/jbc.M109.022012","volume":"285","author":"Y Nishimoto","year":"2010","unstructured":"Nishimoto, Y. et al. Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43. J. Biol. Chem. 285, 608\u2013619 (2010).","journal-title":"J. Biol. Chem."},{"key":"61676_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"SC Ling","year":"2013","unstructured":"Ling, S. C., Polymenidou, M. & Cleveland, D. W. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79, 416\u2013438 (2013).","journal-title":"Neuron"},{"key":"61676_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ebiom.2017.09.005","volume":"24","author":"G Shiihashi","year":"2017","unstructured":"Shiihashi, G. et al. Dendritic Homeostasis Disruption in a Novel Frontotemporal Dementia Mouse Model Expressing Cytoplasmic Fused in Sarcoma. EBioMedicine 24, 102\u2013115 (2017).","journal-title":"EBioMedicine"},{"key":"61676_CR9","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1093\/brain\/aww161","volume":"139","author":"G Shiihashi","year":"2016","unstructured":"Shiihashi, G. et al. Mislocated FUS is sufficient for gain-of-toxic-function amyotrophic lateral sclerosis phenotypes in mice. Brain 139, 2380\u20132394 (2016).","journal-title":"Brain"},{"key":"61676_CR10","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1172\/JCI72723","volume":"124","author":"H Qiu","year":"2014","unstructured":"Qiu, H. et al. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J. Clin. Invest. 124, 981\u2013999 (2014).","journal-title":"J. Clin. Invest."},{"key":"61676_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17209-0","volume":"7","author":"K Mitsuhashi","year":"2017","unstructured":"Mitsuhashi, K. et al. De novo design of RNA-binding proteins with a prion-like domain related to ALS\/FTD proteinopathies. Sci. Rep. 7, 16871 (2017).","journal-title":"Sci. Rep."},{"key":"61676_CR12","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/nn.4065","volume":"18","author":"M Prudencio","year":"2015","unstructured":"Prudencio, M. et al. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat. Neurosci. 18, 1175\u20131182 (2015).","journal-title":"Nat. Neurosci."},{"key":"61676_CR13","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.neuron.2018.12.036","volume":"101","author":"C Tan","year":"2019","unstructured":"Tan, C. et al. Endothelium-Derived Semaphorin 3\u2009G Regulates Hippocampal Synaptic Structure and Plasticity via Neuropilin-2\/PlexinA4. Neuron 101, 920\u2013937 e913 (2019).","journal-title":"Neuron"},{"key":"61676_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep00603","volume":"2","author":"B Rogelj","year":"2012","unstructured":"Rogelj, B. et al. Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain. Sci. Rep. 2, 603 (2012).","journal-title":"Sci. Rep."},{"key":"61676_CR15","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1093\/nar\/gkv157","volume":"43","author":"Y Yu","year":"2015","unstructured":"Yu, Y. et al. U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish. Nucleic Acids Res. 43, 3208\u20133218 (2015).","journal-title":"Nucleic Acids Res."},{"key":"61676_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.nbd.2013.03.003","volume":"55","author":"V Gerbino","year":"2013","unstructured":"Gerbino, V., Carri, M. T., Cozzolino, M. & Achsel, T. Mislocalised FUS mutants stall spliceosomal snRNPs in the cytoplasm. Neurobiol. Dis. 55, 120\u2013128 (2013).","journal-title":"Neurobiol. Dis."},{"key":"61676_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7171","volume":"6","author":"S Sun","year":"2015","unstructured":"Sun, S. et al. ALS-causative mutations in FUS\/TLS confer gain and loss of function by altered association with SMN and U1-snRNP. Nat. Commun. 6, 6171 (2015).","journal-title":"Nat. Commun."},{"key":"61676_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00401-012-1043-z","volume":"125","author":"JC Mitchell","year":"2013","unstructured":"Mitchell, J. C. et al. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol. 125, 273\u2013288 (2013).","journal-title":"Acta Neuropathol."},{"key":"61676_CR19","doi-asserted-by":"crossref","unstructured":"Ling, S. C. et al. Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axis. Elife 8 (2019).","DOI":"10.7554\/eLife.40811"},{"key":"61676_CR20","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.1093\/hmg\/ddt328","volume":"22","author":"M Sabatelli","year":"2013","unstructured":"Sabatelli, M. et al. Mutations in the 3\u2019 untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis. Hum. Mol. Genet. 22, 4748\u20134755 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"61676_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5335","volume":"5","author":"S Dini Modigliani","year":"2014","unstructured":"Dini Modigliani, S., Morlando, M., Errichelli, L., Sabatelli, M. & Bozzoni, I. An ALS-associated mutation in the FUS 3\u2032-UTR disrupts a microRNA-FUS regulatory circuitry. Nat. Commun. 5, 4335 (2014).","journal-title":"Nat. Commun."},{"key":"61676_CR22","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1093\/brain\/awz217","volume":"142","author":"GE Tyzack","year":"2019","unstructured":"Tyzack, G. E. et al. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis. Brain 142, 2572\u20132580 (2019).","journal-title":"Brain"},{"key":"61676_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04373-8","volume":"9","author":"R Luisier","year":"2018","unstructured":"Luisier, R. et al. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS. Nat. Commun. 9, 2010 (2018).","journal-title":"Nat. Commun."},{"key":"61676_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31132-y","volume":"8","author":"C Barham","year":"2018","unstructured":"Barham, C. et al. RNA-Seq Analysis of Spinal Cord Tissues from hPFN1(G118V) Transgenic Mouse Model of ALS at Pre-symptomatic and End-Stages of Disease. Sci. Rep. 8, 13737 (2018).","journal-title":"Sci. Rep."},{"key":"61676_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"61676_CR26","doi-asserted-by":"publisher","first-page":"W333","DOI":"10.1093\/nar\/gkw410","volume":"44","author":"JW Park","year":"2016","unstructured":"Park, J. W., Jung, S., Rouchka, E. C., Tseng, Y. T. & Xing, Y. rMAPS: RNA map analysis and plotting server for alternative exon regulation. Nucleic Acids Res. 44, W333\u2013338 (2016).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61676-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61676-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61676-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:36:28Z","timestamp":1670315788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61676-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["61676"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-61676-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"assertion":[{"value":"28 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4857"}}